Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: Any benefits?

Journal of Perinatology

Volumn 32, Issue 1, 2012, Pages 64-69

  Nyp, M ^a   Sandritter, T ^b   Poppinga, N ^a   Simon, C ^a   Truog, W E ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

BPD; bronchopulmonary dysplasia; iNO; pulmonary hypertension; sildenafil

Indexed keywords

NITRIC OXIDE; OXYGEN; SILDENAFIL;

ARTICLE; BRONCHOPULMONARY DYSPLASIA ASSOCIATED PULMONARY HYPERTENSION; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FRACTIONAL INSPIRED OXYGEN; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; HUMAN; HYPOTENSION; INFANT; INFANT MORTALITY; LUNG ARTERY PRESSURE; LUNG DYSPLASIA; LUNG GAS EXCHANGE; MALE; MEDICAL RECORD REVIEW; PREMATURITY; PULMONARY HYPERTENSION; RESPIRATORY SEVERITY SCORE; RESPIRATORY TRACT PARAMETERS; RIGHT VENTRICULAR PEAK SYSTOLIC PRESSURE; SCORING SYSTEM; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PULMONARY GAS EXCHANGE; PURINES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SULFONES; TREATMENT OUTCOME;

EID: 84855274801     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.131     Document Type: Article

References (21)

1. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era. Pediatrics 2007; 120(6): 1260-1269. (Pubitemid 350223677)
2. Kulik TJ, Rhein LM, Mullen MP. Pulmonary arterial hypertension in infants with chronic lung disease: Will we ever understand it? J Pediatr 2010; 157(2): 186-190.
3. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Badesch D, Fleming T et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353: 2148-2157. (Pubitemid 41653106)
4. Bhatia S, Frantz RP, Severson CJ, Durst LA, McGoon MD. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy. Mayo Clin Proc 2003; 78: 1207-1213. (Pubitemid 37193511)
5. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 2010; 181: 270-278.
6. Steinhorn RH, Kinsella JP, Pierce C, Butrous G, Dilleen M, Oakes M et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 2009; 155: 841-847.
7. Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: A pilot randomized blinded study. Pediatrics 2006; 117(4): 1077-1083. (Pubitemid 46071498)
8. Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 2009; 154: 379-384.
9. Krishnan U. Management of pulmonary arterial hypertension in the neonatal unit. Cardiol Rev 2010; 18: 73-75.
10. Ehrenkranz R, Walsh M, Vohr B, Jobe A, Wright L, Fanaroff A et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-1360. (Pubitemid 46056482)
11. Skinner J, Stuart A, O'Sullivan J, Heads A, Boys R, Hunter S. Right heart pressure determination by Doppler in infants with tricuspid regurgitation. Arch Dis Child 1993; 69(2): 216-220. (Pubitemid 23267366)
12. Mourani P, Sontag M, Younoszia A, Ivy D, Abman S. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121: 317-325. (Pubitemid 351198454)
13. Hawkins A, Tulloh R. Treatment of pediatric pulmonary hypertension. Vasc Health Risk Manag 2009; 5: 509-524.
14. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355(4): 343-353. (Pubitemid 44127537)
15. Benaron DA, Benitz. Maximizing the stability of oxygen delivered via nasal cannula. Arch Pediatr Adolesc Med 1994; 148(3): 294-300. (Pubitemid 24083978)
16. Check J, Harvey C, Matoba N, Porta N, Gotteiner N, Mestan K. Intrauterine growth restriction in BPD infants with pulmonary hypertension: A case-control study. Publisher E-PAS 20113835.357.
17. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 2005; 15(172): 750-756. (Pubitemid 41324231)
18. Visser Y, Walther F, Laghmani E, Boersma H, Laarse A, Wagenaar G. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Resp Res 2009; 10: 30-46.
19. Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Pediatr Cardiol 2008; 29(6): 1082-1086.
20. Humpl T, Reyes J, Erickson S, Armano R, Holtby H, Adatia I. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease. Cardiol Young 2010; 8: 1-7. [Epub ahead of print].
21. Caputo S, Furcolo G, Rabuano R, Basilicata AM, Pilla LM, De Simone A et al. Severe pulmonary arterial hypertension in a very premature baby with broncho pulmonary dysplasia: Normalization with long-term sildenafil. J Cardiovasc Med (Hagerstown) 2010; 11(9): 704-706.